SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-088297
Filing Date
2016-01-06
Accepted
2016-01-06 08:50:14
Documents
6
Period of Report
2016-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-25733_28k.htm 8-K 36977
2 EX-4.1 a15-25733_2ex4d1.htm EX-4.1 114919
3 EX-5.1 a15-25733_2ex5d1.htm EX-5.1 18761
4 EX-10.1 a15-25733_2ex10d1.htm EX-10.1 234087
5 EX-99.1 a15-25733_2ex99d1.htm EX-99.1 11001
6 GRAPHIC g257332kki001.jpg GRAPHIC 3295
  Complete submission text file 0001104659-16-088297.txt   421823
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 161325393
SIC: 2834 Pharmaceutical Preparations